Wednesday, 12 August 2020

Biovest to spin off CMO business

16 March 2016 | News | By BioSpectrum Bureau

Biovest to spin off CMO business

Cell Culture Company is the new spin off of Biovest International

Cell Culture Company is the new spin off of Biovest International

Singapore: Biovest International has decided to spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named Cell Culture Company.

Cell Culture Company will supply automated single-use perfusion bioreactor systems and custom mammalian cell and protein manufacturing services to the diagnostic, therapeutic, and animal healthcare industries.

Since the late 1990s, Biovest's primary focus has been the commercialization of personalized immunotherapies. That work will continue under the Biovest name. "The spin-off of Cell Culture Company will ensure that our instrument and CMO customers will be better served through increased focus and investment," said Christiaan Engstrom, president, Cell Culture Company President.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls